Dimensional Fund Advisors
SNNA

Dimensional Fund Advisors’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Dimensional Fund Advisors’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-73,990
Closed -$64K – 3460
2019
Q2 		$64K Sell
73,990
-7,251
-9% -$11.4K ﹤0.01% 3420
2019
Q1 		$188K Buy
81,241
+65,932
+431% +$179K ﹤0.01% 3319
2018
Q4 		$36K Buy
+15,309
New +$135K ﹤0.01% 3410

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Dimensional Fund Advisors's SNNA Position: Q3 2019 in Review

Dimensional Fund Advisors sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 73,990 shares — an estimated $64K sold.

Dimensional Fund Advisors first reported a position in SNNA in Q4 2018 and held it in 3 quarters. The position peaked at $188K in Q1 2019. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

  • Dimensional Fund Advisors reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Dimensional Fund Advisors sold 73,990 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $64K.
  • Dimensional Fund Advisors first reported a position in Sienna Biopharmaceuticals, Inc. in Q4 2018 and held it in 3 quarters.
  • Dimensional Fund Advisors's Sienna Biopharmaceuticals, Inc. position peaked at $188K in Q1 2019.
  • 23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Dimensional Fund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.